TotalMarketCap

Aura Biosciences

AURANasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$659.563 M

$6.36 -4.36%

Close of 6 Nov 2026

As of 6 Nov 2026, Aura Biosciences (AURA) has a market capitalization of $659.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$106.2M

Loss-making

Shares outstanding

103,704,809

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #53Solid BiosciencesSLDB$686.4M
  2. #54Attovia TherapeuticsATTO$684.1M
  3. #55Aura BiosciencesAURA$659.6M
  4. #56Ginkgo BioworksDNA$646.9M
  5. #57Bambusa TherapeuticsBBTX$631.2M

What if Aura Biosciences were worth as much as…

Open the what-if tool →

Gold $28.2T

$272,281.24

Per share 42,812× higher

Bitcoin $1.53T

$14,732.66

Per share 2,316× higher

Apple $5.02T

$48,365.96

Per share 7,605× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Aura Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.